The Dutch giant now poised for much better times
29/04/24 -"While our earnings estimates have reset higher, the extent of the upgrade is limited compared with the fundamental metrics (DCF and NAV) given that our numbers are already on the high side when ..."
Pages
65
Language
English
Published on
29/04/24
You may also be interested by these reports :
17/05/24
Clariane communicated more details regarding its projected capital increases and the entry of a new anchor shareholder in its capital. We take this ...
17/05/24
We have incorporated the detailed information provided by Clariane regarding its projected capital increases. This has resulted in only minor changes ...
16/05/24
On the back of the promising beginning to 2024, which was a combination of 1/ normalising market demand in Europe (the lynchpin geography); 2/ the ...
16/05/24
As we have consistently argued over the last 3 years, Health stocks (ex Pharma) are long on growth promises and short on delivery. The gap stems from ...